SELLAS Life Sciences Group, Inc. (SLS)

3.98 +0.14 (+3.65%) USD  |  NASDAQ  |  Jan 16, 16:00
4.12 +0.14 (+3.52%) After-Hours: 20:00
More

SELLAS Life Sciences Group Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade